Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VIDI198.007)
Received: 14 February 2022
Accepted: 15 June 2022
First Online: 8 July 2022
: Ethical approval was received from the Institutional Review Board of the Netherlands Cancer Institute in Amsterdam (Approval Number IRBd20-205). All participants completed an informed consent before participating in the interview study.
: Not applicable.
: The authors declare that they have no competing interests.